Description
Product Introduction
Zomelis 50mg Tablet is an oral antidiabetic medication used in the management of type 2 diabetes mellitus. It is prescribed when lifestyle changes and other medications are not sufficient to control blood sugar levels. This medicine helps reduce the risk of diabetes-related complications such as kidney damage, vision loss, and nerve issues.
How It Works
Zomelis 50mg Tablet contains a DPP-4 inhibitor that increases the release of insulin from the pancreas in response to meals and decreases the amount of sugar produced by the liver. This dual action helps maintain steady blood glucose levels throughout the day.
Usage Instructions
Take Zomelis 50mg Tablet exactly as prescribed by your doctor. It can be taken with or without food, but it should be taken at the same time every day for maximum benefit. Do not chew or crush the tablet. Swallow it whole with a glass of water.
Benefits
Zomelis 50mg Tablet helps lower both fasting and post-meal blood sugar levels. It supports better glycemic control and contributes to the prevention of long-term complications of diabetes. It is often used when diet, exercise, or other medications fail to provide adequate blood sugar control.
Side Effects
Common side effects include hypoglycemia, headache, dizziness, fatigue, nausea, and tremors. These symptoms usually subside as your body adjusts to the medication. However, if they persist or worsen, consult your doctor. It is advisable to carry a quick source of sugar in case symptoms of low blood sugar occur.
Precautions and Safety Advice
Inform your doctor if you have a history of kidney, liver, pancreas, or heart disease. Zomelis 50mg Tablet may not be suitable during pregnancy or breastfeeding unless specifically advised by a healthcare provider. Avoid alcohol as it may increase the risk of hypoglycemia. Use caution when driving or operating machinery, as the medicine may cause drowsiness or blurred vision. Regular monitoring of blood glucose and kidney function may be required during treatment.
Brand
Eris Lifesciences Ltd
